PTO- 1553 |
Approved for use through 12/31/2020. OMB 0651-0054 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Input Field |
Entered |
SERIAL NUMBER | 87361159 |
---|---|
LAW OFFICE ASSIGNED | LAW OFFICE 122 |
EXTENSION OF USE | NO |
MARK SECTION | |
MARK | mark |
LITERAL ELEMENT | BLUEROCK |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
MARK STATEMENT | The mark consists of standard characters, without claim to any particular font style, size or color. |
OWNER SECTION (current) | |
NAME | BlueRock Therapeutics LP |
MAILING ADDRESS | One Broadway, Fifteenth Floor |
CITY | Cambridge |
STATE | Massachusetts |
ZIP/POSTAL CODE | 02142 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
XXXX | |
OWNER SECTION (proposed) | |
NAME | BlueRock Therapeutics LP |
MAILING ADDRESS | One Broadway, Fifteenth Floor |
CITY | Cambridge |
STATE | Massachusetts |
ZIP/POSTAL CODE | 02142 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
XXXX | |
CORRESPONDENCE INFORMATION (current) | |
NAME | Michael A. Lisi |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | info@bridgeip.net |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | NOT PROVIDED |
CORRESPONDENCE INFORMATION (proposed) | |
NAME | Michael A. Lisi |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | info@bridgeip.net |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | NOT PROVIDED |
DOCKET/REFERENCE NUMBER | 369.024195 |
GOODS AND/OR SERVICES SECTION | |
INTERNATIONAL CLASS | 001 |
CURRENT IDENTIFICATION | chemical and biological preparations for medical, industrial and scientific use, namely, body cells and cells of the immune system of mammals, including human cells; analytical kits consisting of chemical reagents for industrial and scientific use, for the purification, detection and immobilization of body cells and cells of the immune system of mammals, including human cells; diagnostic preparations for scientific and research use; combinations of cells and materials, namely, reagents, nucleotides, carrier proteins, encapsulation materials, engineered matrix, diagnostic preparations, scaffolds, polymers, tracers, dyes, hydrogels, activating agents, detergents, stabilisers, emulsifiers, oxidants, antioxidants, vitamins, salts, sugars, amino acids, buffers, nucleic acids and viral vectors for biological scientific and research use |
GOODS OR SERVICES | DELETE ALL ITU GOODS/SERVICES IN THIS CLASS |
WEBPAGE URL | None Provided |
WEBPAGE DATE OF ACCESS | None Provided |
INTERNATIONAL CLASS | 005 |
CURRENT IDENTIFICATION | Cells for medical or clinical use; kits comprised of cells and pharmaceuticals, namely biologics, antibacterials, antivirals, antifungals, anti-inflammatories, therapeutics, small molecules, immuno-suppressants, immune-modulators, pro-drugs, cytokines, growth factors, nucleic acids and viral vectors for medical or clinical use; therapeutic pharmaceuticals for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, renal, aural, respiratory, sensory-neural, urogenital, urological, hematologic, fungal and viral diseases and disorders; pharmaceutical preparations for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, renal, aural, respiratory, sensory-neural, urogenital, urological, hematologic, fungal and viral diseases and disorders; biological preparations for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, renal, aural, respiratory, sensory-neural, urogenital, urological, hematologic, fungal and viral diseases and disorders; Gene therapy products, namely, therapeutics for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, renal, aural, respiratory, sensory-neural, urogenital, urological, hematologic, fungal and viral diseases and disorders |
GOODS OR SERVICES | DELETE ALL ITU GOODS/SERVICES IN THIS CLASS |
WEBPAGE URL | None Provided |
WEBPAGE DATE OF ACCESS | None Provided |
INTERNATIONAL CLASS | 040 |
CURRENT IDENTIFICATION | Manufacturing services for others in the field of pharmaceuticals |
GOODS OR SERVICES | DELETE ALL ITU GOODS/SERVICES IN THIS CLASS |
WEBPAGE URL | None Provided |
WEBPAGE DATE OF ACCESS | None Provided |
INTERNATIONAL CLASS | 042 |
CURRENT IDENTIFICATION | Scientific and industrial research in the field of biochemistry, diagnostics or pharmaceuticals; biochemical or pharmaceutical laboratory services, namely, cultivation and purification of cells, namely, of body cells and cells of the immune system of mammals including human cells; pharmaceutical research and development; medical research, namely, conducting clinical trials for others; providing a website featuring information about investigational medical devices, diagnostics and drugs; Research and development of human therapeutics using gene editing |
GOODS OR SERVICES DELETED FROM THE APPLICATION | Scientific and industrial research in the field of biochemistry, diagnostics or pharmaceuticals; pharmaceutical research and development; medical research, namely, conducting clinical trials for others; providing a website featuring information about investigational medical devices, diagnostics and drugs; Research and development of human therapeutics using gene editing |
GOODS OR SERVICES IN USE IN COMMERCE | Biochemical or pharmaceutical laboratory services, namely, cultivation and purification of cells, namely, of body cells and cells of the immune system of mammals including human cells |
FIRST USE ANYWHERE DATE | 11/25/2020 |
FIRST USE IN COMMERCE DATE | 11/25/2020 |
SPECIMEN FILE NAME(S) | |
ORIGINAL PDF FILE | SPN3-21623410278-20210220 085853941085_._Class_42_s pecimen.pdf |
CONVERTED PDF FILE(S) (3 pages) |
\\TICRS\EXPORT18\IMAGEOUT 18\873\611\87361159\xml4\ SOU0002.JPG |
\\TICRS\EXPORT18\IMAGEOUT 18\873\611\87361159\xml4\ SOU0003.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\873\611\87361159\xml4\ SOU0004.JPG | |
SPECIMEN DESCRIPTION | Mark in use on manual with instructions for use in clinical trial |
WEBPAGE URL | None Provided |
WEBPAGE DATE OF ACCESS | None Provided |
INTERNATIONAL CLASS | 044 |
CURRENT IDENTIFICATION | Providing medical information; providing a web site featuring medical information; providing medical information, consultancy and advisory services; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals |
GOODS OR SERVICES DELETED FROM THE APPLICATION | providing medical information, consultancy and advisory services; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals |
GOODS OR SERVICES IN USE IN COMMERCE | Providing medical information; providing a web site featuring medical information |
FIRST USE ANYWHERE DATE | 02/22/2017 |
FIRST USE IN COMMERCE DATE | 11/25/2020 |
SPECIMEN FILE NAME(S) | |
ORIGINAL PDF FILE | SPN4-21623410278-20210220 085853941085_._Class_44_s pecimen.pdf |
CONVERTED PDF FILE(S) (3 pages) |
\\TICRS\EXPORT18\IMAGEOUT 18\873\611\87361159\xml4\ SOU0005.JPG |
\\TICRS\EXPORT18\IMAGEOUT 18\873\611\87361159\xml4\ SOU0006.JPG | |
\\TICRS\EXPORT18\IMAGEOUT 18\873\611\87361159\xml4\ SOU0007.JPG | |
SPECIMEN DESCRIPTION | Mark in use on manual used in laboratory or clinical trial settings, AND mark in use on applicant's website |
WEBPAGE URL | http://bluerocktx.com/research-development/publications/ |
WEBPAGE DATE OF ACCESS | 02/18/2021 |
REQUEST TO DIVIDE | NO |
PAYMENT SECTION | |
NUMBER OF CLASSES IN USE | 2 |
SUBTOTAL AMOUNT [ALLEGATION OF USE FEE] | 200 |
TOTAL AMOUNT | 200 |
SIGNATURE SECTION | |
DECLARATION SIGNATURE | /Michael A. Lisi/ |
SIGNATORY'S NAME | Michael A. Lisi |
SIGNATORY'S POSITION | Attorney of record, Michigan bar member |
DATE SIGNED | 02/20/2021 |
SIGNATORY'S PHONE NUMBER | 2482844091 |
SIGNATURE METHOD | Signed directly within the form |
FILING INFORMATION | |
SUBMIT DATE | Sat Feb 20 09:25:37 ET 2021 |
TEAS STAMP | USPTO/SOU-XXX.XXX.XXX.XX- 20210220092537537123-8736 1159-77059aef96983f75e66f bd4197d2a039ef52ae4efa517 fe317d29c5a671fcf123-CC-2 5343862-20210220085853941 085 |
PTO- 1553 |
Approved for use through 12/31/2020. OMB 0651-0054 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
The signatory believes that the applicant is the owner of the mark sought to be registered. For a trademark or service mark application, the mark is in use in commerce on or in connection with all the goods/services in the application or notice of allowance, or as subsequently modified. For a collective trademark, collective service mark, collective membership mark application, the applicant is exercising legitimate control over the use of the mark in commerce by members on or in connection with all the goods/services/collective membership organization in the application or notice of allowance, or as subsequently modified. For a certification mark application, the applicant is exercising legitimate control over the use of the mark in commerce by authorized users on or in connection with the all goods/services in the application or notice of allowance, or as subsequently modified, and the applicant is not engaged in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant. |
|
The specimen(s) shows the mark as used on or in connection with the goods/services/collective membership organization in commerce. | |
To the best of the signatory's knowledge and belief, no other persons, except, if applicable, authorized users, members, and/or concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive. | |
To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support. | |
The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true. |